Salivary biomarkers and their usefulness in the early detection of oral cancer

Authors

Keywords:

biomarkers, neoplasms of the mouth, saliva, tumor biomarkers.

Abstract

Introduction: Head and neck cancer is the sixth most common form of human cancer; It is a challenge for Dentistry to reduce mortality and morbidity due to its cause through the development of diagnostic tools that detect it in its early stages.
Objective: To describe the role of salivary biomarkers as a diagnostic tool for the early detection of oral cancer.
Development: Salivary biomarkers provide additional information to that obtained in the histopathological study of this type of cancer and can constitute a non-invasive and low-cost analysis tool for early diagnosis.
Conclusions: Although to date there is no ideal biomarker for the early diagnosis of oral cancer, researchers declare a promising future in the use of saliva as a source of biomarkers for these diseases, due in large part to the direct contact of saliva with the oral mucosa and technological advances in the field of molecular medicine.

Downloads

Download data is not yet available.

Author Biography

José Carlos Alvarez Hernández, Policlínico Universitario Sur. Servicio de Estomatología Sur. Morón

Especialista de Primer Grado en Estomatología General Integral. Profesor Asistente. Investigador Agregado.

References

1. Vásquez-Díaz LM, Meléndez-Hernández LC. Precisión diagnóstica de interleuquina-8 salival para cáncer oral: revisión sistemática. [Trabajo de Grado]. Cartagena de Indias: Universidad de Cartagena. 2021 [acceso: 02/04/2023]. DOI: 10.57799/11227/9778

2. Bastías-Alcalde DE, Maturana-Astudillo AS. Biomarcadores salivales como herramienta diagnóstica para la detección temprana de cáncer oral. Un scoping review. [Tesis de Titulación de Cirujano Dentista]. Chile: Universidad Andrés Bello. 2020 [acceso: 02/04/2023]. Disponible en: http://repositorio.unab.cl/xmlui/handle/ria/18036

3. Meisser-Madera JV, Franco A, Solà I, Bonfill X, Arévalo-Rodríguez I. Diagnostic accuracy of salivary biomarkers for oral cancer and potentially malignant disorders: A systematic review protocol. Medwave. 2020 [acceso: 02/04/2023]; 20(5):e7938. Disponible en: https://www.medwave.cl/medios/medwave/Junio2020/PDF/medwave-2020-05-7938.pdf

4. Organización Mundial de la Salud. Salud bucodental. Suiza: Ginebra; 2022 [acceso: 02/04/2023]. Disponible en: https://www.who.int/news-room/fact-sheets/detail/oral-health

5. National Cancer Institute: SEER Cancer Stat Facts: Oral Cavity and Pharynx Cancer. EE.UU; 2023 [acceso: 02/04/2023]. Disponible en: https://seer.cancer.gov/statfacts/html/oralcav.html

6. American Cancer Society: Cancer Facts and Figures 2023. EE.UU.; 2023. [acceso: 02/04/2023]. Disponible en: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2023/2023-cancer-facts-and-figures.pdf

7. Ministerio de Salud Pública. Dirección de Registros Médicos y Estadística de salud. Anuario Estadístico de Salud 2021. Cuba: La Habana; 2022 [acceso: 02/04/2023]: [aprox. 193 p.]. Disponible en: http://files.sld.cu/bvscuba/files/2020/05/Anuario-Electr%C3%B3nico-Espa%C3%B1ol-2019-ed-2020.pdf

8. Registro Nacional de Cáncer. Anuario de Incidencia de Cáncer en Cuba 2016. Cuba: La Habana; 2021 [acceso: 02/04/2023]. Disponible en: http://www.rnc.sld.cu/wp-content/uploads/2016/07/Anuario_Incidencia-de-C%C3%A1ncer-en-Cuba-2016.pdf

9. Bustos-Lobato L. Biomarcadores salivales para el diagnóstico precoz del cáncer y precáncer oral. Revisión Bibliográfica. [Tesis de Grado en Odontología]. Sevilla: Universidad de Sevilla. 2020 [acceso: 02/04/2023]. Disponible en: https://idus.us.es/handle/11441/104432

10. Juárez RP. Análisis bibliométrico de la producción científica internacional sobre biomarcadores salivales durante el período 2004-2018: Análisis bibliométrico sobre biomarcadores salivales. Rev nac odontol. 2020 [acceso: 20/04/2023]; 16(2):1-16. Disponible en: https://revistas.ucc.edu.co/index.php/od/article/view/3839

11. Barembaum S, Azcurra A. La saliva: una potencial herramienta en la Odontología. Rev de la Facultad de Odontología. 2019 [acceso: 20/04/2023]; 29(2):9-21. Disponible en: https://revistas.unc.edu.ar/index.php/RevFacOdonto/article/view/25250/24496

12. Hema Shree K, Ramani P, Sherlin H, Sukumaran G, Jeyaraj G, Don KR, et al. Saliva as a Diagnostic Tool in Oral Squamous Cell Carcinoma - a Systematic Review with Meta-Analysis. Pathol Oncol Res. 2019 [acceso: 20/04/2023]; 25(2):447-53. Disponible en: https://link.springer.com/article/10.1007/s12253-019-00588-2

13. Chattopadhyay I, Panda M. Recent trends of saliva omics biomarkers for the diagnosis and treatment of oral cancer. J Oral Biosci. 2019 [acceso: 13/05/2023]; 61(2):84-94. Disponible en: https://www.sciencedirect.com/science/article/pii/S1349007918301609

14. Cristaldi M, Mauceri R, Di Fede O, Giuliana G, Campisi G, Panzarella V. Salivary Biomarkers for Oral Squamous Cell Carcinoma Diagnosis and Follow-Up: Current Status and Perspectives. Front Physiol. 2019 [acceso: 26/04/2023]; 10:1476. Disponible en: https://www.frontiersin.org/articles/10.3389/fphys.2019.01476/full

15. de Lima M, Fernandes Dantas R, Mendes J, Costa Neto R, Lima Júnior J, Ximenes de Souza S. Biomarcadores salivares en el diagnóstico y monitoreo de enfermedades bucales y sistémicas. Rev Cubana Estomatol. 2020 [acceso: 16/05/2023]; 57(1):e2139. Disponible en: https://revestomatologia.sld.cu/index.php/est/article/view/2139/1723

16. González Á, Pérez C, Solórzano E, León MdlA, Morales OA. Efectividad de los biomarcadores salivales como medio diagnóstico para el cáncer bucal con base en una revisión sistemática de la literatura. Acta Bioclínica. 2019 [acceso: 12/06/2023]; 9(17):188-228. Disponible en: http://erevistas.saber.ula.ve/index.php/actabioclinica/article/view/14338

17. Panta P, Wong DTW. Salivary Biomarkers in Oral Cancer. In: Panta P, editor. Oral Cancer Detection: Novel Strategies and Clinical Impact Cham: Springer International Publishing. 2019; 2019(1):265-95. DOI: 10.1007/978-3-319-61255-3_14

18. Shan J, Sun Z, Yang J, Xu J, Shi W, Wu Y, et al. Discovery and preclinical validation of proteomic biomarkers in saliva for early detection of oral squamous cell carcinomas . Oral Diseases. 2019 [acceso: 26/04/2023]; 25(1):97-107. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1111/odi.12971

19. Kallalli BN, Rawson K, Muzammil, Singh A, Awati MA, Shivhare P. Lactate dehydrogenase as a biomarker in oral cancer and oral submucous fibrosis. Journal of Oral Pathology and Medicine. 2016 [acceso: 26/04/2023]; 45(9):687-90. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1111/jop.12451

20. Zheng J, Sun L, Yuan W, Xu J, Yu X, Wang F, et al. Clinical value of Naa10p and CEA levels in saliva and serum for diagnosis of oral squamous cell carcinoma. Journal of Oral Pathology and Medicine. 2018 [acceso: 26/04/2023]; 47(9):830-5. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1111/jop.12767

21. Singh P, Verma JK, Singh JK. Validation of Salivary Markers, IL-1ß, IL-8 and Lgals3bp for Detection of Oral Squamous Cell Carcinoma in an Indian Population. Scientific Reports. 2020; 10(1):7365. DOI: 10.1038/s41598-020-64494-3 .

22. Sinevici N, Mittermayr S, Davey GP, Bones J, O'Sullivan J. Salivary N-glycosylation as a biomarker of oral cancer: A pilot study. Glycobiology. 2019 [acceso: 26/04/2023]; 29(10):726-34. Disponible en: https://academic.oup.com/glycob/article-abstract/29/10/726/5523900

23. Endo S, Matsunaga T, Nishinaka T. The role of AKR1B10 in physiology and pathophysiology. Metabolites. 2021; 11(332): [aprox. 23p.]. DOI:10.3390/metabo11060332.

24. Sabarathinam J, Selvaraj J, Devi S. Estimation of levels of glutathione peroxidase (GPX), malondialdehyde (MDA), tumor necrosis factor alpha (TNF-a) and alpha Feto protein (AFP) in saliva of potentially malignant disorders and oral squamous cell carcinoma. Biomedical and Pharmacology Journal. 2019; 12(4):1881-6. DOI: 10.13005/bpj/1818 .

25. Li SX, Yang YQ, Jin LJ, Cai ZG, Sun Z. Detection of survivin, carcinoembryonic antigen and ErbB2 level in oral squamous cell carcinoma patients. Cancer Biomarkers. 2017 [acceso: 26/04/2023]; 17(4):377-82. Disponible en: https://content.iospress.com/articles/cancer-biomarkers/cbm651

26. Wang CI, Yu CJ, Huang Y, Yi JS, Cheng HW, Kao HK, et al. Association of overexpressed karyopherin alpha 2 with poor survival and its contribution to interleukin-1ß-induced matrix metalloproteinase expression in oral cancer. Head and Neck. 2018 [acceso: 26/04/2023]; 40(8):1719-33. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1002/hed.25145

27. Pérez Mateo R. Análisis transcriptómico completo de miRNAs en la progresión del carcinoma escamoso de piel con tecnología EdgeSeq. [Tesis de Grado en Biotegnología]. Valencia: Universidad Politécnica de Valencia. 2019 [acceso: 12/06/2023]. Disponible en: http://hdl.handle.net/10251/124004

28. Salvatierra Cáceres E, Salinas Rodríguez J, Hidalgo Rivas A, Sánchez Astorga M. Capacidad diagnóstica de los biomarcadores salivales interleucinas 6 y 8 para el diagnóstico de carcinoma de células escamosas de cavidad oral. Av en Odontoestomatol. 2017 [acceso: 26/04/2023]; 33(2):67-75. Disponible en: https://scielo.isciii.es/scielo.php?pid=S0213-12852017000200003&script=sci_arttext

29. Sivadasan P, Gupta MK, Sathe G, Sudheendra H V, Sunny SP, Renu D, et al. Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection Journal of Proteomics. 2020; 212:103574. DOI: 10.1016/j.jprot.2019.103574

Downloads

Published

2024-05-24

How to Cite

1.
Reyes Tejera L, Fernández González OL, Alvarez Hernández JC. Salivary biomarkers and their usefulness in the early detection of oral cancer. Rev Cubana Med Milit [Internet]. 2024 May 24 [cited 2025 Apr. 3];53(2):e024026095. Available from: https://revmedmilitar.sld.cu/index.php/mil/article/view/26095

Issue

Vol. 53 No. 2 (2024): April - June

Section

Review Article

License

Authors who have publications with this Journal accept the following terms:

  • The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
  • The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
  • Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.